Form D/A — Cytogel Pharma, LLC
0001213900-26-034790 · filed Mar 26, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $16,000,000
- Reported amount sold
- $0
- Minimum investment
- $50,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cytogel Pharma, LLC
- CIK
- 1491841
- Entity
- Limited Liability Company
- Jurisdiction
- CONNECTICUT
- Year incorporated
- —
- Address
- 3 THORNDAL CIRCLE
DARIEN, Connecticut 06820 - Phone
- 203-966-9867
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
C. Dean Maglaris · Executive OfficerNew Canaan, Connecticut Find on LinkedIn ↗
-
Jerry P. Leamon · DirectorCos Cob, Connecticut Find on LinkedIn ↗
-
Cassandra Klimp · DirectorSouthport, Connecticut Find on LinkedIn ↗
-
Frederick W. Telling · Executive OfficerPort Orange, Florida Find on LinkedIn ↗
-
Steven Chrust · DirectorBrooklyn, New York Find on LinkedIn ↗
-
Michael Ullmann · DirectorPrinceton, New Jersey Find on LinkedIn ↗
-
Eric Lang · DirectorPlainsboro, New Jersey Find on LinkedIn ↗
-
Theodore Maione · Executive OfficerTroy, New York Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗